Personalised medicine for cancer, including brain tumours has been on the tips of scientists tongues for a little while now, and with this piece of research it looks like we’re just starting to see some real progress…
New research in America has shown that a small percentage (3%) of glioblastomas are caused by a genetic mutation where two separate genes fuse into one. Using mice, scientists targeted chemicals at the glioblastoma cells which have this gene fusion, and discovered it dramatically slowed the progresion of the disease.
Professor Stephen Emerson, director of the Herbert Irving Comprehensive Cancer Centre at Columbia University Medical Centre said the study was ‘perhaps a first step toward a personalised, precision approach to the treatment of glioblastoma’.
The article was first published in Scientist, subscribers can read it here:
Not a subscriber? Simply click here instead: